|
NPEPPS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.8939999981209E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73560000038542E-07 |
| Normal-vs-Stage2 |
3.554400E-02 |
| Normal-vs-Stage3 |
5.63749999999974E-05 |
| Normal-vs-Stage4 |
3.94540000000498E-05 |
| Stage1-vs-Stage2 |
1.928440E-01 |
| Stage1-vs-Stage3 |
8.199200E-01 |
| Stage1-vs-Stage4 |
9.488800E-01 |
| Stage2-vs-Stage3 |
2.923200E-01 |
| Stage2-vs-Stage4 |
2.444400E-01 |
| Stage3-vs-Stage4 |
8.893800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.71599999765348E-08 |
| Normal-vs-AfricanAmerican |
1.787610E-04 |
| Normal-vs-Asian |
6.047300E-04 |
| Caucasian-vs-AfricanAmerican |
7.915800E-01 |
| Caucasian-vs-Asian |
9.762000E-01 |
| AfricanAmerican-vs-Asian |
7.987600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.31670000000661E-05 |
| Normal-vs-Female |
8.76910000169318E-08 |
| Male-vs-Female |
5.258400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.0585000037876E-08 |
| Normal-vs-Age(41-60Yrs) |
3.34629999998448E-06 |
| Normal-vs-Age(61-80Yrs) |
1.816130E-03 |
| Normal-vs-Age(81-100Yrs) |
8.189600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.239760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.250400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.101900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.443600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.559800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.651400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.136200E-01 |
| Classical-VS-Follicular |
2.85882428840978E-13 |
| Classical-VS-Other |
3.400400E-01 |
| Classical-VS-Normal |
3.70280472949958E-11 |
| Tall-VS-Follicular |
9.68549999980084E-07 |
| Tall-VS-Other |
2.333000E-01 |
| Tall-VS-Normal |
1.97717000000042E-05 |
| Follicular-VS-Other |
1.298990E-01 |
| Follicular-VS-Normal |
4.630400E-01 |
| Other-VS-Normal |
1.007830E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.156740E-03 |
| Normal-vs-N1 |
1.102920E-03 |
| N0-vs-N1 |
2.149400E-01 |
|
|
